Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr 4:27:100512.
doi: 10.1016/j.ijcha.2020.100512. eCollection 2020 Apr.

Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy

Affiliations
Editorial

Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy

Thomas H Schindler et al. Int J Cardiol Heart Vasc. .
No abstract available

Keywords: Cardiac magnetic resonance imaging; Cardiovascular risk; Flow gradient; Hypertrophic cardiomyopathy; Myocardial blood flow; Myocardial flow reserve; Positron emission tomography.

PubMed Disclaimer

Comment on

  • Hypertrophic cardiomyopathy.
    Antunes MO, Scudeler TL. Antunes MO, et al. Int J Cardiol Heart Vasc. 2020 Mar 25;27:100503. doi: 10.1016/j.ijcha.2020.100503. eCollection 2020 Apr. Int J Cardiol Heart Vasc. 2020. PMID: 32309534 Free PMC article. Review.

References

    1. Veselka J., Anavekar N.S., Charron P. Hypertrophic obstructive cardiomyopathy. Lancet. 2017;389:1253–1267. - PubMed
    1. Poli S., Facchin D., Rizetto F. Prognostic role of non-sustained ventricular tachycardia detected with remote interrogation in a pacemaker population. Int. J. Cardiol. Heart. Vasc. 2019;22:92–95. - PMC - PubMed
    1. Valenta I., Szabo Z., Mathews W.B., Abraham T.P., Abraham M.R., Schindler T.H. PET/CT imaging of cardiac angiotensin II Type 1 receptors in nonobstructive hypertrophic cardiomyopathy. JACC Cardiovasc. Imaging. 2019;12:1895–1896. - PubMed
    1. Bravo P.E., Zimmermann S.L., Luo H.C. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ. Cardiovasc. Imaging. 2013;6:210–217. - PMC - PubMed
    1. Ogano M., Iwasaki Y.K., Tsuboi I. Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy. Int. J. Cardiol. Heart. Vasc. 2019;22:78–81. - PMC - PubMed

LinkOut - more resources